Cytophage Technologies Ltd. (TSXV:CYTO)

Canada flag Canada · Delayed Price · Currency is CAD
0.1750
-0.0050 (-2.78%)
Jan 21, 2026, 10:45 AM EST
-32.69%
Market Cap12.18M
Revenue (ttm)n/a
Net Income (ttm)-4.57M
Shares Out67.69M
EPS (ttm)-0.08
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume14,000
Average Volume41,854
Open0.1850
Previous Close0.1800
Day's Range0.1750 - 0.1850
52-Week Range0.1250 - 0.3950
Beta0.08
RSI55.07
Earnings DateApr 30, 2026

About Cytophage Technologies

Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name; and water-soluble solution for livestock producers under the FarmPhage name. The company is headquartered in Oak Bluff, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Steven Theriault
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol CYTO
Full Company Profile

Financial Performance

Financial Statements